Technological interventions to address cardiovascular health disparities impacting racial minorities: Opportunities

Audrey Todd1, Carl J Lavie2, Shady Abohashem3

  • 1Stanford University School Medicine, 291 Campus Drive, Stanford, CA 94305, USA; Health Disparities Think Tank, USA.

Insights

Racial minorities face higher cardiovascular disease (CVD) risks. Digital health tools (mHealth) show promise but require community partnerships, improved digital literacy, and better access for equitable adoption.

Area of Science:

  • Public Health
  • Health Disparities
  • Digital Health Equity

Background:

  • Racial minority groups experience disproportionately higher rates of cardiovascular disease (CVD) compared to White Americans.
  • Contributing factors include socioeconomic disadvantages, hazardous living environments, and limited healthcare access.

Purpose of the Study:

  • To explore the potential of digital health (mHealth) technologies for managing CVD in minority populations.
  • To identify barriers and propose solutions for equitable mHealth adoption in underrepresented communities.

Main Methods:

  • Review of existing literature on mHealth adoption and health disparities.
  • Analysis of challenges such as digital health literacy, cultural relevance, and healthcare distrust.

Main Results:

  • mHealth offers a promising avenue for personalized health management and community engagement.
  • Significant barriers hinder widespread adoption among minority groups, including digital literacy gaps and distrust.

Conclusions:

  • Policy interventions are crucial to foster community-centered mHealth development.
  • Enhancing digital health literacy and ensuring equitable access are key to reducing CVD disparities.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
245
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
331